KR860008976A - 2-(4-벤조일-1- 피페리딜)-1- 페닐알칸올 유도체 - Google Patents

2-(4-벤조일-1- 피페리딜)-1- 페닐알칸올 유도체 Download PDF

Info

Publication number
KR860008976A
KR860008976A KR1019860003714A KR860003714A KR860008976A KR 860008976 A KR860008976 A KR 860008976A KR 1019860003714 A KR1019860003714 A KR 1019860003714A KR 860003714 A KR860003714 A KR 860003714A KR 860008976 A KR860008976 A KR 860008976A
Authority
KR
South Korea
Prior art keywords
compound
formula
process according
salt
general formula
Prior art date
Application number
KR1019860003714A
Other languages
English (en)
Inventor
고디이예 베르나르
루쏘 장
Original Assignee
에뚜레 레메뜨르
신떼라보 소시에떼 아노님
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에뚜레 레메뜨르, 신떼라보 소시에떼 아노님 filed Critical 에뚜레 레메뜨르
Publication of KR860008976A publication Critical patent/KR860008976A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Insulating Materials (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

내용 없음

Description

2-(4-벤조일-1-피페리딜)-1-페닐알칸올 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

  1. (a) 일반식(Ⅴ)
    (여기서 R은 수소 또는 메틸이고 R1은 비치환 페닐, 4-메톡시-3,5-디메틸페닐 또는 2-, 3-또는 4-위치중 하나에서 할로겐, C1-4알킬, C1-4알콕시, 히드록시, 벤질옥시, 트리플루오로메틸, 시아노, 니트로, 아미노, 아세틸아미노, 메틸티오, 메틸술포닐 또는 아미노술포닐에 의해 치환된 페닐이고 R2는 비치환 페닐, 2,4,6-트리메톡시페닐 또는 3-또는 4-위치중 하나에서 불소, 염소, 메틸 또는 메톡시에 의해 치환된페닐이다)의 화합물을 산으로 처리하거나 또는 (b) 일반식 (Ⅵ)
    의 화합물을 일반식 (Ⅵ)
    의 화합물과 반응시키고 그리하여 형성된 일반식(I)
    (상기 Ⅵ,Ⅶ 및 I식에서 R,R1및 R2는 일반식 Ⅴ에서 정의 한 대로이다)의 화합물을 그후 임의적으로 더 어상의 일반식(I)의 화합물로 전환시키거나 또는 일반식(I)의 염기를 해당염으로 전환시이거나 또는 염을 일반식(I)의 해당염기로 전키시키는 것으로 이루어지는 것을 특징으로 하는 일반식(I)의 화합물또는 그의 산부가 염의 제조방법.
  2. 제1항에 있어서, R1은 할로게노페닐 도는 알킬페닐이고 R2는 플루오로페닐인 것을 특징으로 하는 제조방법.
  3. 제1항에 있어서, 제약상 허용되는 산과의 산부가 염의 형태인 것을 특징으로 하는 제조방법.
  4. 제1항 내지 제3항중 어느 하나에 있어서, 순수한 광학이성질체의 형태인 것을 특징으로 하는 제조방법.
  5. 일반식(Ⅱ)
    (여기서 R 및 R1은 제1항에서 정의한 바와 같고 X는 염소 또는 브롬이다)의 화합물을 일반식(Ⅲ)
    (여기서 R2는 제1항에서 정의한 바와 같다)의 화합물과 반응시킴으로써 임의적으로 염의 형태로 일반식 (Ⅳ)
    의 화합물을 생성시킨 다음 일반식 (Ⅳ)의 화합물을 환원시킴으로써 일반식(Ⅴ)
    의 화합물을 얻는 것을 특징으로 하는 일반식 (Ⅴ)의 화합물의 제조방법.
  6. 제5항에 있어서, 할로겐화케톤(Ⅲ)을 염의 형태인 디옥솔라닐피페리딘(Ⅳ)과 용매중에서 염기의 존재하에 반응시키는 것을 특징으로 하는 제조방법.
  7. 제5항 또는 제6항에 있어서, 화합물(Ⅳ)을 수소 화붕소 알칼리금속에 의해 환원시키는 것을 특징으로 하는 제조방법.
  8. 제7항에 있어서, 아세트산의 존재하에 환원을 수행하는 것을 특징으로 하는 제조방법.
  9. 제8항에 있어서, 산의 부재하에 환원을 수행하는 것을 특징으로 하는 제조방법.
  10. 제1항의 제조방법에 의해 제조되는 모든 일반식(Ⅰ)의 화합물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019860003714A 1985-05-14 1986-05-13 2-(4-벤조일-1- 피페리딜)-1- 페닐알칸올 유도체 KR860008976A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8507270A FR2581993B1 (fr) 1985-05-14 1985-05-14 Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
FR85/07270 1985-05-14

Publications (1)

Publication Number Publication Date
KR860008976A true KR860008976A (ko) 1986-12-19

Family

ID=9319247

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860003714A KR860008976A (ko) 1985-05-14 1986-05-13 2-(4-벤조일-1- 피페리딜)-1- 페닐알칸올 유도체

Country Status (18)

Country Link
US (1) US4711899A (ko)
EP (1) EP0202164B1 (ko)
JP (1) JPS61260063A (ko)
KR (1) KR860008976A (ko)
AT (1) ATE40684T1 (ko)
AU (1) AU584701B2 (ko)
DE (1) DE3662044D1 (ko)
DK (1) DK220386A (ko)
ES (2) ES8802138A1 (ko)
FI (1) FI861995A (ko)
FR (1) FR2581993B1 (ko)
GR (1) GR861253B (ko)
HU (1) HU195640B (ko)
IL (1) IL78773A (ko)
NO (1) NO861897L (ko)
NZ (1) NZ216145A (ko)
PT (1) PT82569B (ko)
ZA (1) ZA863533B (ko)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910006138B1 (ko) * 1986-09-30 1991-08-16 에자이 가부시끼가이샤 환상아민 유도체
JP2573195B2 (ja) * 1986-09-30 1997-01-22 エーザイ株式会社 環状アミン誘導体
US4870083A (en) * 1987-11-24 1989-09-26 Merrell Dow Pharmaceuticals Inc. 1,4-Disubstituted-piperidinyl compounds useful as analgesics and muscle relaxants
US5166211A (en) * 1987-12-17 1992-11-24 Merrell Dow Pharmaceuticals Inc. Method of using 1,4-disubstituted piperidinyl compounds in the treatment of coronary vasospasons and variant angina
US5093341A (en) * 1987-12-17 1992-03-03 Merrell Dow Pharmaceuticals Inc. N-aralkyl piperidine derivatives useful as antithrombolytic agents
US5064838A (en) * 1988-01-21 1991-11-12 Merrell Dow Pharmaceuticals 1,4-disubstituted-piperidinyl compounds as pain relievers
FR2634206B1 (fr) * 1988-07-12 1992-05-15 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2 et quinoleinones-2, leur preparation et leur application en therapeutique
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique
GB8823775D0 (en) * 1988-10-11 1988-11-16 Scras New 2-carbonyl substituted n n'-di-(trimethoxybenzoyl)piperazines
GB8823776D0 (en) * 1988-10-11 1988-11-16 Scras New 2-methoxycarbonyl sustituted n n'-di-(trimethoxybenzoyl)piperazines
US4994460A (en) * 1989-06-01 1991-02-19 Bristol-Myers Squibb Co. Agents for treatment of brain ischemia
US5055470A (en) * 1989-06-01 1991-10-08 Bristol-Myers Squibb Co. Method of treatment of ischemia in brain
NZ236501A (en) * 1989-12-21 1992-12-23 Merrell Dow Pharma Piperidine derivatives and antithrombotic compositions
US5292752A (en) * 1989-12-21 1994-03-08 Merrell Dow Pharmaceuticals Inc. Antithrombotic compounds
EP0554247B1 (en) * 1990-05-10 2000-04-26 Pfizer Inc. Neuroprotective indolone and related derivatives
US5478846A (en) * 1990-06-07 1995-12-26 Merrell Dow Pharmaceuticals Inc. 1-piperidinyl alkanoylanyl sulfonamides for treatment of cardiac arrhythmia
ES2096651T3 (es) * 1990-06-07 1997-03-16 Merrell Pharma Inc Derivados de 1-piperidinil alcanoilarilsulfonamida.
US5512584A (en) * 1991-04-16 1996-04-30 Basf Aktiengesellschaft 1,3,4-trisubstituted piperidine derivatives, the preparation and use thereof
FR2678269B1 (fr) * 1991-06-27 1995-01-13 Synthelabo Derives de 1-(4-chlorophenyl)-2-[4-(2-phenylethyl)piperidin-1-yl]ethanol, leur application et leur preparation en therapeutique.
FR2688504B1 (fr) * 1992-03-13 1995-05-05 Synthelabo Derives de 2-(piperidin-1-yl)ethanol, leur preparation et leur application en therapeutique.
US5436255A (en) * 1992-07-23 1995-07-25 Pfizer Inc. Method of treating diseases susceptable to treatment by blocking NMDA-receptors
US5498610A (en) * 1992-11-06 1996-03-12 Pfizer Inc. Neuroprotective indolone and related derivatives
NZ275151A (en) * 1994-01-31 1998-02-26 Pfizer 3r*4s*3-[4-(4-fluorophenyl)-4-hydroxy-piperidin-1-yl]-chroman-4 ,7-diol; isomers and salts
FR2737494B1 (fr) * 1995-08-04 1997-08-29 Synthelabo Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
US6770659B2 (en) * 2002-08-26 2004-08-03 Sk Corporation Benzoyl piperidine compounds
US20050158270A1 (en) * 2004-01-15 2005-07-21 Seren Frantz Pearlizer concentrate and its use in personal care compositions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH492708A (de) * 1968-01-11 1970-06-30 Geigy Ag J R Verfahren zur Herstellung von neuen Piperidinderivaten
US3632767A (en) * 1968-02-12 1972-01-04 Mallinckrodt Chemical Works Treatment of depression with 4-substituted piperidines
US3576810A (en) * 1968-06-20 1971-04-27 Robins Co Inc A H 1-substituted-3-(-4)-aroylpiperidines
BE791088A (fr) * 1971-11-09 1973-03-01 Richardson Merrell Inc Nouveaux derives d'aryl (piperidyl-4) cetone, utiles notamment comme analgesiques et anticoagulants, et leur procede de preparation
US4101662A (en) * 1973-05-03 1978-07-18 A. H. Robins Company, Incorporated Method for inhibiting emesis and compositions therefor
GB1535791A (en) * 1975-05-07 1978-12-13 Ferrosan Ab Derivatives of 4-piperidinol
US4035369A (en) * 1975-10-08 1977-07-12 Janssen Pharmaceutica N.V. 1-Benzazolylalkyl-4-substituted-piperidines
CH602642A5 (ko) * 1975-11-14 1978-07-31 Orgamol Sa
FR2408602A2 (fr) * 1977-11-15 1979-06-08 Synthelabo Nouveaux derives de piperidine et leur methode de preparation
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
US4198419A (en) * 1979-01-10 1980-04-15 American Hoechst Corporation Phenylthiophenylpiperidines
US4443451A (en) * 1981-07-15 1984-04-17 Janssen Pharmaceutica N.V. Bicyclic pyrimidin-5-one derivatives
FR2534580A1 (fr) * 1982-10-13 1984-04-20 Synthelabo Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent
DK159420C (da) * 1983-03-09 1991-03-11 Ciba Geigy Ag N-(piperidinyl-alkyl)-carboxamider og salte deraf, farmaceutiske praeparater indeholdende disse forbindelser samt anvendelsen af forbindelserne til fremstilling af antipsykotiske farmaceutiske praeparater
US4458076A (en) * 1983-05-31 1984-07-03 Hoechst-Roussel Pharmaceuticals 3-(4-Piperidinyl)-1,2-benzisothiazoles

Also Published As

Publication number Publication date
PT82569A (fr) 1986-06-01
DE3662044D1 (en) 1989-03-16
AU584701B2 (en) 1989-06-01
PT82569B (fr) 1988-04-12
HUT40790A (en) 1987-02-27
IL78773A0 (en) 1986-08-31
NZ216145A (en) 1988-10-28
IL78773A (en) 1990-09-17
ES554895A0 (es) 1988-04-01
ES8802138A1 (es) 1988-04-01
US4711899A (en) 1987-12-08
ES8801631A1 (es) 1988-02-16
GR861253B (en) 1986-09-10
ATE40684T1 (de) 1989-02-15
FR2581993B1 (fr) 1988-03-18
AU5740686A (en) 1986-11-20
ES557582A0 (es) 1988-02-16
FI861995A0 (fi) 1986-05-13
DK220386A (da) 1986-11-15
HU195640B (en) 1988-06-28
EP0202164B1 (fr) 1989-02-08
EP0202164A1 (fr) 1986-11-20
NO861897L (no) 1986-11-17
ZA863533B (en) 1986-12-30
DK220386D0 (da) 1986-05-13
FR2581993A1 (fr) 1986-11-21
JPS61260063A (ja) 1986-11-18
FI861995A (fi) 1986-11-15

Similar Documents

Publication Publication Date Title
KR860008976A (ko) 2-(4-벤조일-1- 피페리딜)-1- 페닐알칸올 유도체
KR860007252A (ko) 아졸릴메틸옥시란의 제조방법
KR880000433A (ko) 이미다조피리딘 및 중간체 화합물의 제조방법
KR860000292A (ko) 벤조푸란유도체의 제조방법
KR890012982A (ko) 치환된 1,2,4-트리아진디온, 이의 제조방법 및 용도
KR870003100A (ko) 벤즈이미다졸 유도체
KR850005827A (ko) 2-치환페닐-3-클로로테트라히드로-2h-인다졸류의 제조방법
KR970006302A (ko) 4-아미노-3-아실나프티리딘 유도체
KR920004381A (ko) 치환된 피리미딘 유도체, 이의 제조방법 및 약제로서의 이의 용도
KR850001166A (ko) 1-치환된 4-하이드록시메틸-피롤리디논 유도체의 제조방법
KR890701564A (ko) 퀴놀린 카복실산 유도체를 제조하는 방법
KR840001152A (ko) 신규 복소환(複素環) 화합물의 제법
KR880013885A (ko) 비사이클 설폰아미드 유도체 및 그의 제조방법
KR880011103A (ko) 5-아미노-4,6-디할로게노피리딘의 제조방법
KR840001974A (ko) 1-[3-(6-플루오로-1,2-벤즈이속사졸-3-일)프로필]-4-(치환된)-피페라진 및-피레리딘의 제조방법
KR890002013A (ko) 치환된 피리딜알킬 케톤의 제조방법
ES2068663T3 (es) Procedimiento para la preparacion de compuestos de piridina sustituidos con halogenosulfonilo.
KR860700352A (ko) 2--(1-피페라지닐)-4-치환 페닐퀴놀린 유도체와 그 염의 제조방법
KR870000292A (ko) 테트라메틸사이클로프로판카복실레이트의 제조방법
SE8705196L (sv) Pyrimidinderivat
KR930019635A (ko) 3-히드록시메틸-1-프로파르길이미다졸리딘-2,4-디온의 제조방법
KR890002011A (ko) 5-할로 게노-6-아미노-니코틴산 할라이드. 이의 제조방법 및 용도
KR850004583A (ko) 페닐아세트아닐리드 유도체의 제조방법
KR860004001A (ko) 할로겐화 3,3-디메틸-5-헥센-2-온의 제조방법
KR940014351A (ko) 신규 피리미딘 티온 화합물 및 이의 제조방법

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid